204 related articles for article (PubMed ID: 33017849)
1. Anabolic-Androgenic Steroid Abuse Impairs Fibrin Clot Lysis.
Sidelmann JJ; Gram JB; Rasmussen JJ; Kistorp C
Semin Thromb Hemost; 2021 Feb; 47(1):11-17. PubMed ID: 33017849
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
Szczepaniak P; Zabczyk M; Undas A
PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
[TBL] [Abstract][Full Text] [Related]
3. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
Morishima Y; Honda Y
J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
[TBL] [Abstract][Full Text] [Related]
4. Reductions in plasmin inhibitor and fibrinogen predict the improved fibrin clot lysis 6 months after obesity surgery.
Pedersen NB; Stolberg CR; Mundbjerg LH; Juhl CB; Gram B; Funch-Jensen P; de Maat MPM; Münster AB; Bladbjerg EM
Clin Obes; 2020 Dec; 10(6):e12397. PubMed ID: 32827201
[TBL] [Abstract][Full Text] [Related]
5. Procoagulant State in Current and Former Anabolic Androgenic Steroid Abusers.
Chang S; Rasmussen JJ; Frandsen MN; Schou M; Johansen ML; Faber J; Münster AB; Sidelmann JJ; Kistorp C
Thromb Haemost; 2018 Apr; 118(4):647-653. PubMed ID: 29618151
[TBL] [Abstract][Full Text] [Related]
6. Fibrin clot properties in women heterozygous for factor V Leiden mutation: effects of oral contraceptives.
Krzek M; Ciesla-Dul M; Zabczyk M; Undas A
Thromb Res; 2012 Oct; 130(4):e216-21. PubMed ID: 22940058
[TBL] [Abstract][Full Text] [Related]
7. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
Nielsen VG; Steenwyk BL; Gurley WQ
J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
[TBL] [Abstract][Full Text] [Related]
8. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
[TBL] [Abstract][Full Text] [Related]
10. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of clot lysis time by a direct thrombin inhibitor melagatran mediated by paradoxical enhancement of thrombin generation: comparison with a direct factor Xa inhibitor edoxaban.
Morishima Y; Kamisato C; Honda Y
Blood Coagul Fibrinolysis; 2021 Apr; 32(3):209-215. PubMed ID: 33560005
[TBL] [Abstract][Full Text] [Related]
12. Altered plasma fibrin clot properties in essential thrombocythemia.
Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
[TBL] [Abstract][Full Text] [Related]
13. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
[TBL] [Abstract][Full Text] [Related]
14. Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system.
Suzuki Y; Sano H; Mochizuki L; Honkura N; Urano T
Blood Adv; 2020 Nov; 4(21):5501-5511. PubMed ID: 33166409
[TBL] [Abstract][Full Text] [Related]
15. Determinants of plasma fibrin clot lysis measured using three different assays in healthy subjects.
Siudut J; Iwaniec T; Plens K; Pieters M; Undas A
Thromb Res; 2021 Jan; 197():1-7. PubMed ID: 33157491
[TBL] [Abstract][Full Text] [Related]
16. Fibrin lysability is associated with central obesity and inflammation in women with polycystic ovary syndrome.
Godtfredsen ACM; Sidelmann JJ; Gram JB; Andersen M; Glintborg D
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1078-1084. PubMed ID: 32048272
[TBL] [Abstract][Full Text] [Related]
17. Effects of gastric bypass followed by a randomized study of physical training on markers of coagulation activation, fibrin clot properties, and fibrinolysis.
Stolberg CR; Mundbjerg LH; Funch-Jensen P; Gram B; Juhl CB; Bladbjerg EM
Surg Obes Relat Dis; 2018 Jul; 14(7):918-926. PubMed ID: 29706497
[TBL] [Abstract][Full Text] [Related]
18. Fibrin Network Formation and Lysis in Septic Shock Patients.
Larsen JB; Aggerbeck MA; Larsen KM; Hvas CL; Hvas AM
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502446
[TBL] [Abstract][Full Text] [Related]
19. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
Kwasny-Krochin B; Gluszko P; Undas A
Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
[TBL] [Abstract][Full Text] [Related]
20. Bidirectional functions of thrombin on fibrinolysis: Evidence of thrombin-dependent enhancement of fibrinolysis provided by spontaneous plasma clot lysis.
Tomczyk M; Suzuki Y; Sano H; Brzoska T; Tanaka H; Urano T
Thromb Res; 2016 Jul; 143():28-33. PubMed ID: 27179129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
